Natural History of the Central Structural Abnormalities in Choroideremia: A Prospective Cross-Sectional Study

Ophthalmology

Volumn 124, Issue 3, 2017, Pages 359-373

  Aleman, Tomas S ^a   Han, Grace ^a   Serrano, Leona W ^a   Fuerst, Nicole M ^a   Charlson, Emily S ^a   Pearson, Denise J ^a   Chung, Daniel C ^a   Traband, Anastasia ^a   Pan, Wei ^a   Ying, Gui shuang ^a   Bennett, Jean ^a   Maguire, Albert M ^a   Morgan, Jessica I W ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGED; CENTRAL RETINA; CENTRAL RETINAL THICKNESS; CHILD; CHOROIDEREMIA; CONFERENCE PAPER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DIAGNOSTIC IMAGING; GENE DELETION; HEMIZYGOTE; HISTORY; HUMAN; MAJOR CLINICAL STUDY; MISSENSE MUTATION; NEAR INFRARED ECTANCE IMAGING; NONSENSE MUTATION; OPTICAL COHERENCE TOMOGRAPHY DEVICE; PHOTORECEPTOR OUTER SEGMENT; PRIORITY JOURNAL; PROSPECTIVE STUDY; RETINA FOVEA; RETINAL INNER NUCLEAR LAYER; RETINAL OUTER NUCLEAR LAYER; RETINAL PIGMENT EPITHELIUM; SPECTRAL DOMAIN OPTICAL COHERENCE TOMOGRAPHY; VISUAL ACUITY; VISUAL THRESHOLD; MIDDLE AGED; OPTICAL COHERENCE TOMOGRAPHY; PATHOLOGY; PHYSIOLOGY; RETINA NERVE CELL; VISUAL FIELD;

ADOLESCENT; ADULT; AGED; CHILD; CHOROIDEREMIA; CROSS-SECTIONAL STUDIES; HUMANS; MIDDLE AGED; PROSPECTIVE STUDIES; RETINAL NEURONS; RETINAL PIGMENT EPITHELIUM; TOMOGRAPHY, OPTICAL COHERENCE; VISUAL ACUITY; VISUAL FIELDS;

EID: 85008190950     PISSN: 01616420     EISSN: 15494713     Source Type: Journal    
DOI: 10.1016/j.ophtha.2016.10.022     Document Type: Conference Paper

References (87)

1. 1 Kurstjens, J.H., Choroideremia and gyrate atrophy of the choroid and retina. Doc Ophthalmol 19 (1965), 1–122.
2. 2 McCulloch, C., Choroideremia: a clinical and pathologic review. Trans Am Ophthalmol Soc 67 (1969), 142–195.
3. 3 MacDonald, I.M., Hume, S., Chan, S., Seabra, M.C., Choroideremia. Pagon, R.A., Adam, M.P., Ardinger, H.H., et al. (eds.) GeneReviews® [Internet], 1993-2016, University of Washington, Seattle, Seattle, WA Available at: http://www.ncbi.nlm.nih.gov/books/NBK1337/ Accessed September 23, 2016.
4. 4 Kärnä, J., Choroideremia. A clinical and genetic study of 84 Finnish patients and 126 female carriers. Acta Ophthalmol Suppl 176 (1986), 1–68.
5. 5 McCulloch, C., McCulloch, R.J., A hereditary and clinical study of choroideremia. Trans Am Acad Ophthalmol Otolaryngol 52 (1948), 160–190.
6. 6 Hayakawa, M., Fujiki, K., Hotta, Y., et al. Visual impairment and REP-1 gene mutations in Japanese choroideremia patients. Ophthalmic Genet 20 (1999), 107–115.
7. 7 Duncan, J.L., Aleman, T.S., Gardner, L.M., et al. Macular pigment and lutein supplementation in choroideremia. Exp Eye Res 74 (2002), 371–381.
8. 8 Jacobson, S.G., Cideciyan, A.V., Sumaroka, A., et al. Remodeling of the human retina in choroideremia: rab escort protein 1 (REP-1) mutations. Invest Ophthalmol Vis Sci 47 (2006), 4113–4120.
9. 9 Roberts, M.F., Fishman, G.A., Roberts, D.K., et al. Retrospective, longitudinal, and cross sectional study of visual acuity impairment in choroideraemia. Br J Ophthalmol 86 (2002), 658–662.
10. 10 Heon, E., Alabduljalil, T., Iii, D.B., et al. Visual function and central retinal structure in choroideremia. Invest Ophthalmol Vis Sci 57 (2016), OCT377–OCT387.
11. 11 Nabholz, N., Lorenzini, M.C., Bocquet, B., et al. Clinical evaluation and cone alterations in choroideremia. Ophthalmology 123 (2016), 1830–1832.
12. 12 Coussa, R.G., Traboulsi, E.I., Choroideremia: a review of general findings and pathogenesis. Ophthalmic Genet 33 (2012), 57–65.
13. 13 Seitz, I.P., Zhour, A., Kohl, S., et al. Multimodal assessment of choroideremia patients defines pre-treatment characteristics. Graefes Arch Clin Exp Ophthalmol 253 (2015), 2143–2150.
14. 14 Pameyer, J.K., Waardenburg, P.J., Henkes, H.E., Choroideremia. Br J Ophthalmol 44 (1960), 724–738.
15. 15 Cremers, F.P., van de Pol, D.J., van Kerkhoff, L.P., et al. Cloning of a gene that is rearranged in patients with choroideraemia. Nature 347 (1990), 674–677.
16. 16 Merry, D.E., Jänne, P.A., Landers, J.E., et al. Isolation of a candidate gene for choroideremia. Proc Natl Acad Sci U S A 89 (1992), 2135–2139.
17. 17 Sankila, E.M., Tolvanen, R., van den Hurk, J.A., et al. Aberrant splicing of the CHM gene is a significant cause of choroideremia. Nat Genet 1 (1992), 109–113.
18. 18 van Bokhoven, H., Schwartz, M., Andréasson, S., et al. Mutation spectrum in the CHM gene of Danish and Swedish choroideremia patients. Hum Mol Genet 3 (1994), 1047–1051.
19. 19 van den Hurk, J.A., Schwartz, M., van Bokhoven, H., et al. Molecular basis of choroideremia (CHM): mutations involving the Rab escort protein-1 (REP-1) gene. Hum Mutat 9 (1997), 110–117.
20. 20 Seabra, M.C., Brown, M.S., Goldstein, J.L., Retinal degeneration in choroideremia: deficiency of rab geranylgeranyl transferase. Science 259 (1993), 377–381.
21. 21 Seabra, M.C., Mules, E.H., Hume, A.N., Rab GTPases, intracellular traffic and disease. Trends Mol Med 8 (2002), 23–30.
22. 22 MacDonald, I.M., Mah, D.Y., Ho, Y.K., et al. A practical diagnostic test for choroideremia. Ophthalmology 105 (1998), 1637–1640.
23. 23 MacDonald, I.M., Sereda, C., McTaggart, K., Mah, D., Choroideremia gene testing. Expert Rev Mol Diagn 4 (2004), 478–484.
24. 24 Seabra, M.C., Ho, Y.K., Anant, J.S., Deficient geranylgeranylation of Ram/Rab27 in choroideremia. J Biol Chem 270 (1995), 24420–24427.
25. 25 Preising, M., Ayuso, C., Rab escort protein 1 (REP1) in intracellular traffic: a functional and pathophysiological overview. Ophthalmic Genet 25 (2004), 101–110.
26. 26 Sergeev, Y.V., Smaoui, N., Sui, R., et al. The functional effect of pathogenic mutations in Rab escort protein 1. Mutat Res 665 (2009), 44–50.
27. 27 Dimopoulos, I.S., Chan, S., MacLaren, R.E., MacDonald, I.M., Pathogenic mechanisms and the prospect of gene therapy for choroideremia. Expert Opin Orphan Drugs 3 (2015), 787–798.
28. 28 Zhang, A.Y., Mysore, N., Vali, H., et al. Choroideremia is a systemic disease with lymphocyte crystals and plasma lipid and RBC membrane abnormalities. Invest Ophthalmol Vis Sci 56 (2015), 8158–8165.
29. 29 Jacobson, S.G., Cideciyan, A.V., Aguirre, G.D., et al. Improvement in vision: a new goal for treatment of hereditary retinal degenerations. Expert Opin Orphan Drugs 3 (2015), 563–575.
30. 30 Jacobson, S.G., Cideciyan, A.V., Roman, A.J., et al. Improvement and decline in vision with gene therapy in childhood blindness. N Engl J Med 372 (2015), 1920–1926.
31. 31 Bennett, J., Wellman, J., Marshall, K.A., et al. Safety and durability of effect of contralateral-eye administration of AAV2 gene therapy in patients with childhood-onset blindness caused by RPE65 mutations: a follow-on phase 1 trial. Lancet 388 (2016), 661–672.
32. 32 Pierce, E.A., Bennett, J., The status of RPE65 gene therapy trials: safety and efficacy. Cold Spring Harb Perspect Med, 5, 2015, a017285.
33. 33 MacLaren, R.E., Groppe, M., Barnard, A.R., et al. Retinal gene therapy in patients with choroideremia: initial findings from a phase 1/2 clinical trial. Lancet 383 (2014), 1129–1137.
34. 34 Edwards, T.L., Jolly, J.K., Groppe, M., et al. Visual acuity after retinal gene therapy for choroideremia. N Engl J Med 374 (2016), 1996–1998.
35. 35 Chan, S.C., Bubela, T., Dimopoulos, I.S., et al. Choroideremia research: report and perspectives on the second international scientific symposium for choroideremia. Ophthalmic Genet 8 (2016), 1–9.
36. 36 Huckfeldt, R.M., Bennett, J., Promising first steps in gene therapy for choroideremia. Hum Gene Ther 25 (2014), 96–97.
37. 37 Curcio, C.A., Messinger, J.D., Sloan, K.R., et al. Human chorioretinal layer thicknesses measured in macula-wide, high-resolution histologic sections. Invest Ophthalmol Vis Sci 52 (2011), 3943–3954.
38. 38 Jacobson, S.G., Voigt, W.J., Parel, J.M., et al. Automated light- and dark-adapted perimetry for evaluating retinitis pigmentosa. Ophthalmology 93 (1986), 1604–1611.
39. 39 Aleman, T.S., Cideciyan, A.V., Sumaroka, A., et al. Retinal laminar architecture in human retinitis pigmentosa caused by rhodopsin gene mutations. Invest Ophthalmol Vis Sci 49 (2008), 1580–1590.
40. 40 Fuerst, N.M., Serrano, L., Han, G., et al. Detailed functional and structural phenotype of Bietti crystalline dystrophy associated with mutations in CYP4V2 complicated by choroidal neovascularization. Ophthalmic Genet 30 (2016), 1–8.
41. 41 Liang, K.Y., Zeger, S.L., Longitudinal data analysis using generalized linear models. Biometrika 73 (1986), 13–22.
42. 42 Cideciyan, A.V., Swider, M., Jacobson, S.G., Autofluorescence imaging with near-infrared excitation: normalization by reflectance to reduce signal from choroidal fluorophores. Invest Ophthalmol Vis Sci 56 (2015), 3393–3406.
43. 43 Lazow, M.A., Hood, D.C., Ramachandran, R., et al. Transition zones between healthy and diseased retina in choroideremia (CHM) and Stargardt disease (STGD) as compared to retinitis pigmentosa (RP). Invest Ophthalmol Vis Sci 52 (2011), 9581–9590.
44. 44 Xue, K., Oldani, M., Jolly, J.K., et al. Correlation of optical coherence tomography and autofluorescence in the outer retina and choroid of patients with choroideremia. Invest Ophthalmol Vis Sci 57 (2016), 3674–3684.
45. 45 Aleman, T.S., Cideciyan, A.V., Sumaroka, A., et al. Inner retinal abnormalities in X-linked retinitis pigmentosa with RPGR mutations. Invest Ophthalmol Vis Sci 48 (2007), 4759–4765.
46. 46 Cour, M., Friis, J., Macular holes: classification, epidemiology, natural history and treatment. Acta Ophthalmol Scand 80 (2002), 579–587.
47. 47 Zinkernagel, M.S., Groppe, M., MacLaren, R.E., Macular hole surgery in patients with end-stage choroideremia. Ophthalmology 120 (2013), 1592–1596.
48. 48 Shinoda, H., Koto, T., Fujiki, K., et al. Clinical findings in a choroideremia patient who underwent vitrectomy for retinal detachment associated with macular hole. Jpn J Ophthalmol 55 (2011), 169–171.
49. 49 Sorsby, A., Franceschetti, A., Joseph, R., Davey, J.B., Choroideremia; clinical and genetic aspects. Br J Ophthalmol 36 (1952), 547–581.
50. 50 Syed, R., Sundquist, S.M., Ratnam, K., et al. High-resolution images of retinal structure in patients with choroideremia. Invest Ophthalmol Vis Sci 54 (2013), 950–961.
51. 51 Morgan, J.I., Han, G., Klinman, E., et al. High-resolution adaptive optics retinal imaging of cellular structure in choroideremia. Invest Ophthalmol Vis Sci 55 (2014), 6381–6397.
52. 52 Katz, B.J., Yang, Z., Payne, M., et al. Fundus appearance of choroideremia using optical coherence tomography. Adv Exp Med Biol 572 (2006), 57–61.
53. 53 Jia, Y., Bailey, S.T., Hwang, T.S., et al. Quantitative optical coherence tomography angiography of vascular abnormalities in the living human eye. Proc Natl Acad Sci U S A 112 (2015), E2395–E2402.
54. 54 Genead, M.A., McAnany, J.J., Fishman, G.A., Retinal nerve fiber thickness measurements in choroideremia patients with spectral-domain optical coherence tomography. Ophthalmic Genet 32 (2011), 101–106.
55. 55 Genead, M.A., Fishman, G.A., Cystic macular oedema on spectral-domain optical coherence tomography in choroideremia patients without cystic changes on fundus examination. Eye (Lond) 25 (2011), 84–90.
56. 56 Francis, P.J., Fishman, G.A., Trzupek, K.M., et al. Stop mutations in exon 6 of the choroideremia gene, CHM, associated with preservation of the electroretinogram. Arch Ophthalmol 123 (2005), 1146–1149.
57. 57 Garcia-Hoyos, M., Lorda-Sanchez, I., Gómez-Garre, P., et al. New type of mutations in three Spanish families with choroideremia. Invest Ophthalmol Vis Sci 49 (2008), 1315–1321.
58. 58 Huang, A.S., Kim, L.A., Fawzi, A.A., Clinical characteristics of a large choroideremia pedigree carrying a novel CHM mutation. Arch Ophthalmol 130 (2012), 1184–1189.
59. 59 Mura, M., Sereda, C., Jablonski, M.M., et al. Clinical and functional findings in choroideremia due to complete deletion of the CHM gene. Arch Ophthalmol 125 (2007), 1107–1113.
60. 60 Coussa, R.G., Kim, J., Traboulsi, E.I., Choroideremia: effect of age on visual acuity in patients and female carriers. Ophthalmic Genet 33 (2012), 66–73.
61. 61 Esposito, G., De Falco, F., Tinto, N., et al. Comprehensive mutation analysis (20 families) of the choroideremia gene reveals a missense variant that prevents the binding of REP1 with Rab geranylgeranyl transferase. Hum Mutat 32 (2011), 1460–1469.
62. 62 Grover, S., Alexander, K.R., Fishman, G.A., Ryan, J., Comparison of intraocular light scatter in carriers of choroideremia and X-linked retinitis pigmentosa. Ophthalmology 109 (2002), 159–163.
63. 63 Grover, S., Alexander, K.R., Choi, D.M., Fishman, G.A., Intraocular light scatter in patients with choroideremia. Ophthalmology 105 (1998), 1641–1645.
64. 64 Iino, Y., Fujimaki, T., Fujiki, K., Murakami, A., A novel mutation (967-970+2)delAAAGGT in the choroideremia gene found in a Japanese family and related clinical findings. Jpn J Ophthalmol 52 (2008), 289–297.
65. 65 Jain, N., Jia, Y., Gao, S.S., et al. Optical coherence tomography angiography in choroideremia: correlating choriocapillaris loss with overlying degeneration. JAMA Ophthalmol 134 (2016), 697–702.
66. 66 Jolly, J.K., Groppe, M., Birks, J., et al. Functional defects in color vision in patients with choroideremia. Am J Ophthalmol 160 (2015), 822–831.
67. 67 Lin, Y., Liu, X., Luo, L., et al. Molecular analysis of the choroideremia gene related clinical findings in two families with choroideremia. Mol Vis 17 (2011), 2564–2569.
68. 68 Ponjavic, V., Abrahamson, M., Andréasson, S., et al. Phenotype variations within a choroideremia family lacking the entire CHM gene. Ophthalmic Genet 16 (1995), 143–150.
69. 69 Renner, A.B., Kellner, U., Cropp, E., et al. Choroideremia: variability of clinical and electrophysiological characteristics and first report of a negative electroretinogram. Ophthalmology 113 (2006), 2066.e1–2066.e10.
70. 70 Rubin, M.L., Fishman, R.S., McKay, R.A., Choroideremia. Study of a family and literature review. Arch Ophthalmol 76 (1966), 563–574.
71. 71 Sanchez-Alcudia, R., Garcia-Hoyos, M., Lopez-Martinez, M.A., et al. A comprehensive analysis of choroideremia: from genetic characterization to clinical practice. PLoS One, 11, 2016, e0151943.
72. 72 Sieving, P.A., Niffenegger, J.H., Berson, E.L., Electroretinographic findings in selected pedigrees with choroideremia. Am J Ophthalmol 101 (1986), 361–367.
73. 73 Lee, T.K., McTaggart, K.E., Sieving, P.A., et al. Clinical diagnoses that overlap with choroideremia. Can J Ophthalmol 38 (2003), 364–372.
74. 74 Rodrigues, M.M., Ballintine, E.J., Wiggert, B.N., et al. Choroideremia: a clinical, electron microscopic, and biochemical report. Ophthalmology 91 (1984), 873–883.
75. 75 Syed, N., Smith, J.E., John, S.K., et al. Evaluation of retinal photoreceptors and pigment epithelium in a female carrier of choroideremia. Ophthalmology 108 (2001), 711–720.
76. 76 MacDonald, I.M., Russell, L., Chan, C.C., Choroideremia: new findings from ocular pathology and review of recent literature. Surv Ophthalmol 54 (2009), 401–407.
77. 77 Wright, A.F., Chakarova, C.F., Abd El-Aziz, M.M., Bhattacharya, S.S., Photoreceptor degeneration: genetic and mechanistic dissection of a complex trait. Nat Rev Genet 11 (2010), 273–284.
78. 78 Milam, A.H., Li, Z.Y., Fariss, R.N., Histopathology of the human retina in retinitis pigmentosa. Prog Retin Eye Res 17 (1998), 175–205.
79. 79 Tolmachova, T., Anders, R., Abrink, M., et al. Independent degeneration of photoreceptors and retinal pigment epithelium in conditional knockout mouse models of choroideremia. J Clin Invest 116 (2006), 386–394.
80. 80 Tolmachova, T., Wavre-Shapton, S.T., Barnard, A.R., et al. Retinal pigment epithelium defects accelerate photoreceptor degeneration in cell type-specific knockout mouse models of choroideremia. Invest Ophthalmol Vis Sci 51 (2010), 4913–4920.
81. 81 Hawkins, R.K., Jansen, H.G., Sanyal, S., Development and degeneration of retina in rds mutant mice: photoreceptor abnormalities in the heterozygotes. Exp Eye Res 41 (1985), 701–720.
82. 82 Ghosh, M., McCulloch, J.C., Pathological findings from two cases of choroideremia. Can J Ophthalmol 15 (1980), 147–153.
83. 83 Rafuse, E.V., McCulloch, C., Choroideremia. A pathological report. Can J Ophthalmol 3 (1968), 347–352.
84. 84 McCulloch, C., McCulloch, R.J., Choroideremia; a hereditary and clinical study. Arch Ophthal 43 (1950), 179–181.
85. 85 Jacobson, S.G., Matsui, R., Sumaroka, A., Cideciyan, A.V., Retinal structure measurements as inclusion criteria for stem cell–based therapies of retinal degenerations. Invest Ophthalmol Vis Sci 57 (2016), ORSFn1–ORSFn9.
86. 86 Duebel, J., Marazova, K., Sahel, J.A., Optogenetics. Curr Opin Ophthalmol 26 (2015), 226–232.
87. 87 Yue, L., Weiland, J.D., Roska, B., Humayun, M.S., Retinal stimulation strategies to restore vision: Fundamentals and systems. Prog Retin Eye Res 53 (2016), 21–47.